메뉴 건너뛰기




Volumn 100, Issue 1 SUPPL. 2, 2008, Pages

Hereditary angiodema: A current state-of-the-art review, VI: Novel therapies for hereditary angioedema

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 11A; BLOOD CLOTTING FACTOR 12A; BRADYKININ B2 RECEPTOR ANTAGONIST; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1S; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C4; DX 88; ENZYME INHIBITOR; ICATIBANT; KALLIKREIN INHIBITOR; PLACEBO; UNCLASSIFIED DRUG;

EID: 38049051713     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60583-2     Document Type: Conference Paper
Times cited : (24)

References (17)
  • 1
    • 33750517560 scopus 로고    scopus 로고
    • Hereditary angioedema: The clinical syndrome and its management in the United States
    • Frank MM. Hereditary angioedema: the clinical syndrome and its management in the United States. Immunol Allergy Clin North Am. 2006;26:653-668.
    • (2006) Immunol Allergy Clin North Am , vol.26 , pp. 653-668
    • Frank, M.M.1
  • 2
    • 0023177623 scopus 로고
    • Autoantibody-mediated acquired deficiency of C1 inhibitor
    • Alsenz J, Bork K, Loos M. Autoantibody-mediated acquired deficiency of C1 inhibitor. N Engl J Med. 1987;316:1360-1366.
    • (1987) N Engl J Med , vol.316 , pp. 1360-1366
    • Alsenz, J.1    Bork, K.2    Loos, M.3
  • 3
    • 50549190821 scopus 로고
    • A biochemical abnormality in hereditary angioneurotic edema: Absence of serum inhibitor of C' 1-esterase
    • Donaldson VH, Evans RR. A biochemical abnormality in hereditary angioneurotic edema: absence of serum inhibitor of C' 1-esterase. Am J Med. 1963;35:37-44.
    • (1963) Am J Med , vol.35 , pp. 37-44
    • Donaldson, V.H.1    Evans, R.R.2
  • 4
    • 0018903687 scopus 로고
    • Replacement therapy in hereditary angioedema: Successful treatment of acute episodes of angioedema with partly purified C1 inhibitor
    • Gadek JE, Hosea SW, Gelfand JA, et al. Replacement therapy in hereditary angioedema: successful treatment of acute episodes of angioedema with partly purified C1 inhibitor. N Engl J Med. 1980;302:542-546.
    • (1980) N Engl J Med , vol.302 , pp. 542-546
    • Gadek, J.E.1    Hosea, S.W.2    Gelfand, J.A.3
  • 6
    • 32844469701 scopus 로고    scopus 로고
    • Hereditary angioedema: New findings concerning symptoms, affected organs, and course
    • Bork K, Meng G, Staubach P, Hardt J. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med. 2006;119:267-274.
    • (2006) Am J Med , vol.119 , pp. 267-274
    • Bork, K.1    Meng, G.2    Staubach, P.3    Hardt, J.4
  • 7
    • 0018419064 scopus 로고
    • Klinik sowie erweiterte diagnostische und therapeutische Moglichkeiten
    • Bork K. Hereditares angioneurotisches Odem: Klinik sowie erweiterte diagnostische und therapeutische Moglichkeiten. Dtsch Med Wochenschrt. 1979;104:405-409.
    • (1979) Dtsch Med Wochenschrt , vol.104 , pp. 405-409
    • Bork, K.1    angioneurotisches Odem, H.2
  • 8
    • 0029973831 scopus 로고    scopus 로고
    • Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate
    • Waytes AT, Rosen FS, Frank MM. Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate. N Engl J Med. 1996;334:1630-1634.
    • (1996) N Engl J Med , vol.334 , pp. 1630-1634
    • Waytes, A.T.1    Rosen, F.S.2    Frank, M.M.3
  • 9
    • 33644759722 scopus 로고    scopus 로고
    • Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency
    • Bork K, Staubach P, Eckardt AJ, Hardt J. Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency. Am J Gastroenterol. 2006;101:619-627.
    • (2006) Am J Gastroenterol , vol.101 , pp. 619-627
    • Bork, K.1    Staubach, P.2    Eckardt, A.J.3    Hardt, J.4
  • 10
    • 33646022921 scopus 로고    scopus 로고
    • Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency
    • Levi M, Choi G, Picavet C, Hack CE. Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency. J Allergy Clin Immunol. 2006;117:904-908.
    • (2006) J Allergy Clin Immunol , vol.117 , pp. 904-908
    • Levi, M.1    Choi, G.2    Picavet, C.3    Hack, C.E.4
  • 11
    • 33845505542 scopus 로고    scopus 로고
    • C1-inhibitor concentrate home therapy for hereditary angioedema: A viable, effective treatment option
    • Longhurst HJ, Carr S, Khair K. C1-inhibitor concentrate home therapy for hereditary angioedema: a viable, effective treatment option. Clin Exp Immunol. 2007;147:11-17.
    • (2007) Clin Exp Immunol , vol.147 , pp. 11-17
    • Longhurst, H.J.1    Carr, S.2    Khair, K.3
  • 12
    • 25844432828 scopus 로고    scopus 로고
    • A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema
    • van Doorn MB, Burggraaf J, van Dam T, et al. A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema. J Allergy Clin Immunol. 2005;116:876-883.
    • (2005) J Allergy Clin Immunol , vol.116 , pp. 876-883
    • van Doorn, M.B.1    Burggraaf, J.2    van Dam, T.3
  • 13
    • 0142169427 scopus 로고    scopus 로고
    • DX-88 and HAE: A developmental perspective
    • Williams A, Baird LG. DX-88 and HAE: a developmental perspective. Transfus Apher Sci. 2003;29:255-258.
    • (2003) Transfus Apher Sci , vol.29 , pp. 255-258
    • Williams, A.1    Baird, L.G.2
  • 14
    • 33748149553 scopus 로고    scopus 로고
    • The therapeutic potential of a kallikrein inhibitor for treating hereditary angioedema
    • Levy JH, O'Donnell PS. The therapeutic potential of a kallikrein inhibitor for treating hereditary angioedema. Expert Opin Investig Drugs. 2006;15:1077-1090.
    • (2006) Expert Opin Investig Drugs , vol.15 , pp. 1077-1090
    • Levy, J.H.1    O'Donnell, P.S.2
  • 15
    • 0141527407 scopus 로고    scopus 로고
    • Approaches toward reversal of increased vascular permeability in C1 inhibitor deficient mice
    • Han Lee ED, Pappalardo E, Scafidi J, Davis AE III. Approaches toward reversal of increased vascular permeability in C1 inhibitor deficient mice. Immunol Lett. 2003;89:155-160.
    • (2003) Immunol Lett , vol.89 , pp. 155-160
    • Han Lee, E.D.1    Pappalardo, E.2    Scafidi, J.3    Davis III, A.E.4
  • 16
    • 33750526677 scopus 로고    scopus 로고
    • Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist Icatibant
    • Bas M, Bier H, Greve J, Kojda G, Hoffmann TK. Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist Icatibant. Allergy. 2006;61:1490-1492.
    • (2006) Allergy , vol.61 , pp. 1490-1492
    • Bas, M.1    Bier, H.2    Greve, J.3    Kojda, G.4    Hoffmann, T.K.5
  • 17
    • 34249801766 scopus 로고    scopus 로고
    • Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant)
    • Bork K, Frank J, Grundt B, Schlattmann P, Nussberger J, Kreuz W. Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant). J Allergy Clin Immunol. 2007;119:1497-1503.
    • (2007) J Allergy Clin Immunol , vol.119 , pp. 1497-1503
    • Bork, K.1    Frank, J.2    Grundt, B.3    Schlattmann, P.4    Nussberger, J.5    Kreuz, W.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.